The Intelligent Dosing System: Application for Insulin Therapy and Diabetes Management
Authors:
- 1 February 2005
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 7 (1) , 58-71
Abstract
Diabetes mellitus is an increasing public health problem. Insulin is an essential tool in the management of hyperglycemia, but methods of dose adjustment are purely empirical. The Intelligent Dosing System (IDS®, Dimensional Dosing Systems, Inc., Wexford, PA) is a software suite that incorporates patient-specific, dose–response data in a mathematical model and then calculates the new dose of the medication needed to achieve the next desired therapeutic goal. We discuss the application of the IDS in insulin management. The IDS concept and the initial modeling used to construct an insulin doser are reviewed first. Additional data are then provided on the use of the IDS for titrating insulin therapy in a clinical setting. Finally, recent modifications in the IDS software and future applications of this technology for insulin dosing and diabetes management are discussed.Keywords
This publication has 32 references indexed in Scilit:
- Global Prevalence of DiabetesDiabetes Care, 2004
- Glycemic Control From 1988 to 2000 Among U.S. Adults Diagnosed With Type 2 DiabetesDiabetes Care, 2004
- Using New Insulin Strategies in the Outpatient Treatment of DiabetesJAMA, 2003
- Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 DiabetesNew England Journal of Medicine, 2003
- The underuse of insulin therapy in North AmericaDiabetes/Metabolism Research and Reviews, 2002
- The Continuing Epidemics of Obesity and Diabetes in the United StatesJAMA, 2001
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyThe Lancet, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993